The College of American Pathologists has urged CMS to reject proposed 2027 Medicare payment changes that could cut pathology reimbursement by up to 34%, citing concerns about access to diagnostic services and the impact on labs.
Read More
CMS has expanded Medicare coverage for non-invasive colorectal cancer screening tests to allow physician associates and advanced practice registered nurses to order assays, including FOBT, according to the American Academy of Physician Associates.
Read More
A new SHEA framework outlines how targeted diagnostic stewardship interventions could save a 200-bed hospital up to $2.8 million annually.
Read More
A nine-lab network evaluated four Bundibugyo virus PCR assays from two manufacturers in two weeks during the 2026 outbreak, establishing new reference standards, according to a study in The Lancet Infectious Diseases.
Read More
Yourgene Health has launched its IVDR-certified DPYD assay in Europe, enabling detection of 19 DPYD gene variants to help clinical labs identify cancer patients at risk of severe toxicity from fluoropyrimidine chemotherapy.
Read More